A cancer diagnosis can be devastating filled with fear and uncertainty. But for one Baldwinsville family, their cancer ...

Fintel reports that on October 17, 2024, HC Wainwright & Co. initiated coverage of Mural Oncology (NasdaqGM:MURA) with a Buy recommendation. Analyst Price Forecast Suggests 258.38% Upside As of ...

Antonious Hazim, MD, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing ...

BioAtla faces a tight cash runway until Q3 2025, raising concerns about dilution and short-term stock headwinds. Find out why ...

On October 3, 2024, Teva Pharmaceuticals and mAbxience, a Fresenius Kabi majority-owned group, announced a new global licensing agreement for the development of an anti PD-1 oncology biosimilar ...

Its opening comes as concerns have mounted over the state of care for cancer patients, with a report presented to the AHS ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Two patients reflected on how extraordinary their oncology nurses are — even noting that they forget about their cancer when ...

The oncology landscape is evolving, with a marked rise in cancer incidence among young adults globally. This challenges the traditional view of cancer as primarily an ailment of the elderly. The ...

Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

Bloodanooga is back at the University of Tennessee at Chattanooga on Oct. 29 and 30. Blood Assurance is encouraging students, ...

Research from the World Health Organisation indicates that there were approximately 20 million new cancer cases globally, and ...